skip to Main Content
ABOUT US

Management

Biogennix is a leading developer of osteobiologic products specifically designed for spine fusion. Founded in 2009, we are led by a team of scientists and industry veterans committed to delivering unique products for bone regeneration. Biogennix designs, manufactures and distributes all of its products from its Irvine facilities located in the heart of Southern California’s “Technology Coast.”

Chris MacDuff
Chris MacDuff

Chief Executive Officer

Chris brings over two decades of diverse sales and marketing management experience to Biogennix. He has spent the last 18 years in the medical device industry, 15 years of which were spent as a successful spine device distributor for Orange County, CA. Chris began his medical device career in marketing at Interpore Cross International, then transitioned into sales management. He later founded Shoreline Surgical Inc., which represented several prominent spine and orthobiologic product lines. Prior to his spine device career, Chris worked for Four Seasons Hotels & Resorts in sales and marketing.  Chris has a B.A. from the University of Rhode Island in Business Administration and Communications.

Edwin-Clayton-Shors
Edwin Clayton Shors, Ph.D.

President

Dr. Shors has a track record of more than 30 years creating unique implantable medical devices for regenerative medicine. He has developed and commercialized synthetic bone graft substitutes, autogenous growth factors and allografts for bone reconstruction, as well as metallic orthopedic and dental implants. Prior to co-founding Biogennix, he was co-founder of Interpore International, which was acquired by Biomet in 2004 for $280 million. From 1978 to 2004, he served in a variety of senior management positions at Interpore International; including President, Chief Technology Officer and Vice President for research and development. Dr. Shors is also President of EC Shors Biomedical Consulting, Inc., which assists device companies with implants for regenerative medicine. Dr. Shors has a Ph.D. degree in Physiology and Biophysics from the University of Southern California.

7R308887 (2)-3
Michael Roux

General Manager

Mr. Roux brings significant business leadership experience to Biogennix.  He has a strong background in product management and marketing with a wide range of medical device and multi-national business expertise with leading publicly-owned and privately held companies.  Most recently, Michael led Product Management at Glidewell Laboratories, a leading dental products technology company. Previously, he served as Vice President of Marketing for Biolase, and as Vice President of Product Management with Patient Safety Technologies, acquired by Stryker in 2014. Prior to that, Michael spent four years as a Director at Hill-Rom, and nineteen years at 3M where he held positions of increasing responsibility within product engineering, six-sigma, global product marketing, and business development. Mr. Roux holds a B.S. in Industrial Engineering from the University of Minnesota, and an M.B.A. in Marketing from the University of St. Thomas.

Robert-2
Robert Baizer

Chief Financial Officer

Mr. Baizer has over 25 years of professional finance experience, with the past 10 years focused specifically in the biotechnology sector.  Most recently, he led a private equity group that partnered with Qualcomm, Inc. to develop a suite of wireless medical devices. Prior to that, Robert formed and led an investment company that provided financing to emerging biotech companies during the financial crisis, which resulted in two portfolio companies becoming publicly traded. He started his finance career with TD Securities (USA) LLC, the investment bank and broker-dealer affiliate of Toronto-Dominion, where he worked from 1993 through 2008.  Most recently, Mr. Baizer was Managing Director responsible for TD’s US derivatives business.  He holds an M.B.A. from Cornell University’s Johnson Graduate School of Management and a B.S. in Electrical Engineering from the University of California San Diego.

7R308877-2
Tim Bumbalough

Chief Technology Officer

Mr. Bumbalough has 30 years experience designing and developing a wide variety of medical devices and implants. Prior to joining Biogennix, Tim held senior research and development positions within Abbott Laboratories, Avail Medical Products, Johnson & Johnson and Interpore International where he made key contributions in the fields of synthetic bone graft substitutes, dental implants, large joint replacement instrumentation, beating heart surgery, vacuum assisted wound closures, and bariatric surgery. Tim has a B.S. degree in Biomedical Engineering from Wright State University and holds numerous patents in electrophysiology, laparoscopic surgery, accommodating intraocular lenses and patient weighing systems.

7R308861-3
Scott Bauccio

Vice President of Sales

Mr. Bauccio has over 17 years of experience in medical device sales and management. Prior to joining Biogennix, Scott held positions in sales management with LDR, Orthofix, and Leica Microsystems; and was responsible for building successful sales channels and teams throughout each organization. After 8 years in food service management, Scott began his medical device sales career with Surgical West, a leading distributor of surgical products, located in Southern California. Scott holds a B.S. in Business Administration from St. Mary’s College of California.

Back To Top
×Close search
Search